港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

诺诚健华

成交量：- -

成交额：- -

市值：- -

市盈率：- -

高：- -

开：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：2.25亿

香港流通股本：2,503.40万

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

市销率: - -

数据加载中...

总览公司新闻资讯公告

诺诚健华在第62届美国血液学协会（ASH）上公布奥布替尼最新临床数据

昌发展投资企业诺诚健华、数坤科技、吉因加取得重大进展

诺诚健华董事长兼CEO崔霁松博士获评2020“年度杰出CEO”

百济神州、和黄医药、亚盛医药、诺诚健华等创新产品即将亮相

药明康德官微

诺诚健华-B盘中异动大幅上涨5.11%

自选股智能写手

诺诚健华童少靖：中国创新药以高质量和高性价比吸引发达国家市场、并受发展中国家市场青睐是必然趋势

金融界网站

诺诚健华“泛癌种”新药启动临床试验

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/90009/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90009","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":0,"timestamp":0,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":25034000,"shares":225290000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"04-17 11:04:08","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1776398400000},"marketStatusCode":2,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":30.6,"timestamp":1776395043000,"preClose":31.3,"halted":0,"volume":6553400,"delay":0,"premium":"-100.00"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90009\",,,,,undefined,":{"symbol":"90009","floatShares":25034000,"roa":"--","roe":"--","lyrEps":0,"shares":225290000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90009\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90009\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90009\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90009\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2089488094","title":"诺诚健华在第62届美国血液学协会（ASH）上公布奥布替尼最新临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2089488094","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2089488094?lang=zh_cn&edition=fundamental","pubTime":"2020-12-07 12:18","pubTimestamp":1607314680,"startTime":"0","endTime":"0","summary":"诺诚健华在第62届美国血液学协会上公布奥布替尼最新临床数据 来源：美通社北京2020年12月7日 /美通社/ -- 生物医药高科技公司诺诚健华今天在第62届美国血液学协会年会上公布了布鲁顿酪氨酸激酶抑制剂奥布替尼最新临床数据。目前，奥布替尼正在中国及美国进行多中心、多适应症的临床试验，研究其作为单药及联合用药的疗效和安全性，临床结果显示了良好的安全性和有效性。现有多个新药产品处于临床及临床前研发阶段。","market":"sh","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-12-07/doc-iiznezxs5622548.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-12-07/doc-iiznezxs5622548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["09969","90009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2084470643","title":"昌发展投资企业诺诚健华、数坤科技、吉因加取得重大进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2084470643","media":"网络","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2084470643?lang=zh_cn&edition=fundamental","pubTime":"2020-11-19 10:44","pubTimestamp":1605753840,"startTime":"0","endTime":"0","summary":"近日，昌发展投资企业在多个方面取得重大突破。昌发展与合作基金联合投资企业诺诚健华今年3月于港交所成功上市，成为2020年第一家在港交所成功上市的生物医药公司。据悉，数坤科技为昌发展间接投资企业，昌发展合作子基金远毅资本和华盖资本参与其融资。","market":"hk","thumbnail":"https://static.tigerbbs.com/769dc8865e0dc507ddea5079c2429001","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/769dc8865e0dc507ddea5079c2429001"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202011191111087a393725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202011191111087a393725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["90009","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2084416290","title":"诺诚健华董事长兼CEO崔霁松博士获评2020“年度杰出CEO”","url":"https://stock-news.laohu8.com/highlight/detail?id=2084416290","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2084416290?lang=zh_cn&edition=fundamental","pubTime":"2020-11-17 10:04","pubTimestamp":1605578640,"startTime":"0","endTime":"0","summary":"诺诚健华董事长兼CEO崔霁松博士获评2020“年度杰出CEO” 来源：美通社北京2020年11月17日 /美通社/ -- 16日晚上，中国知名的全球投资研究平台格隆汇举办的“全球投资嘉年华2020”在成都发布“2020大中华区最佳上市公司”系列榜单，凭借在企业管理和创新领域的卓越表现，诺诚健华联合创始人、董事长兼CEO崔霁松博士获得“2020年度杰出CEO”称号。崔霁松博士于2015年与世界著名结构生物学家施一公教授联合创立诺诚健华。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznctke1840324.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznctke1840324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["90009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2084792497","title":"百济神州、和黄医药、亚盛医药、诺诚健华等创新产品即将亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2084792497","media":"药明康德官微","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2084792497?lang=zh_cn&edition=fundamental","pubTime":"2020-11-17 07:52","pubTimestamp":1605570736,"startTime":"0","endTime":"0","summary":"百济神州、和黄医药、亚盛医药、诺诚健华等创新产品即将亮相 来源：药明康德官微第62届美国血液学会（）年会将于2020年12月5至8日举行。根据ASH年会摘要及公开资料，来自、、亚盛医药、诺诚健华、亘喜生物、等中国公司的众多创新疗法也即将在本次大会上亮相。目前，该产品已在中国提交新药上市申请，且已被纳入优先审评。本届会议上，诺诚健华将以海报的形式展示奥布替尼的多项研究数据。","market":"us","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznezxs2233955.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-11-17/doc-iiznezxs2233955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["159938","09939","06160","90009","BGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2082188015","title":"诺诚健华-B盘中异动 大幅上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2082188015","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2082188015?lang=zh_cn&edition=fundamental","pubTime":"2020-11-09 13:58","pubTimestamp":1604901520,"startTime":"0","endTime":"0","summary":"2020年11月09日下午盘13时58分，诺诚健华-B股票出现异动，股价急速拉升5.11%。截至发稿，该股报11.941港元/股，成交量112.31万股，换手率0.09%，振幅4.93%。诺诚健华-B股票所在的生物技术行业中，整体涨幅为4.46%。其相关个股中，荣昌生物-B、药明巨诺-B、金斯瑞生物科技涨幅较大，振幅较大的相关个股有荣昌生物-B、金斯瑞生物科技、药明巨诺-B，振幅分别为21.31%、13.81%、13.01%。消息层面，截至13时58分，诺诚健华-B股票正面舆情新闻比例50%。","market":"hk","thumbnail":"https://static.tigerbbs.com/8593d7bafc6da002b2ab4975d4711a90","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8593d7bafc6da002b2ab4975d4711a90"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20201109135840797e15ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20201109135840797e15ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["90009","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2072000032","title":"诺诚健华童少靖：中国创新药以高质量和高性价比吸引发达国家市场、并受发展中国家市场青睐是必然趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2072000032","media":"金融界网站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2072000032?lang=zh_cn&edition=fundamental","pubTime":"2020-09-30 11:53","pubTimestamp":1601438013,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202009301201027a222900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202009301201027a222900&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["90009","09969","06978","159992","90014"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2070090418","title":"诺诚健华“泛癌种”新药启动临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2070090418","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2070090418?lang=zh_cn&edition=fundamental","pubTime":"2020-09-27 16:21","pubTimestamp":1601194860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49"],"rights":{"source":"sina_symbol","url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-09-27/doc-iivhuipp6780166.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/relnews/hk/2020-09-27/doc-iivhuipp6780166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["03347","90009"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":69,"code":"91000000","status":"200"}]}}